US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Dec 31, 2025 (8 months ago)

BioGlo Fluorescein Sodium Ophthalmic Strips USP

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.

What was recalled

BioGlo Fluorescein Sodium Ophthalmic Strips USP, 100 diagnostic strips, Manufactured by Omni Lens PVT. Ltd., 5 - Samrudhhi, Opp. Sakar-III, Navrangpura, Ahmedabad, Gujarat, India - 380014, Email:[email protected], Manufactured for & disibruted by: HUB Pharmaceuticals, LLC, 8767 E Via de Ventura #175, Scottsdale, AZ, 85258, NDC 17238-900-11.

Recalling firm
Wizcure Pharmaa Private Limited
NDC code
17238-900-11
Origin
N/A, India
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0352-2026

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Fluorescein recalls

See all
Class II · Moderate risk Ongoing

Bio Glo Fluorescein Sodium Ophthalmic Strips USP

Reason Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.

Wizcure Pharmaa Private Limited NDC 17238-900-30 D-0351-2026
Class II · Moderate risk Ongoing

CHNaO Fluorescein Sodium Ophthalmic Strips

Reason Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.

Wizcure Pharmaa Private Limited NDC 83851-100-10 D-0350-2026
Class III · Low risk Ongoing

Fluorescein 2% Ophth

Reason Subpotent Drug

Boothwyn Pharmacy LLC D-0607-2025
Class II · Moderate risk Ongoing

Ful-Glo

Reason Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.

Nomax Inc NDC 17478-404-01 D-0465-2024
Class II · Moderate risk Ongoing

Ful-Glo

Reason Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.

Nomax Inc NDC 17478-403-03 D-0464-2024